Cargando…
Why rare disease needs precision medicine—and precision medicine needs rare disease
With one in ten suffering from one of 10,000 rare diseases, precision medicine opens a path toward identifying therapies for rare patients. Conversely, it is rare patients—through their collective experience and the knowledge captured in their genetics—who open the path toward identifying therapies...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861960/ https://www.ncbi.nlm.nih.gov/pubmed/35243424 http://dx.doi.org/10.1016/j.xcrm.2022.100530 |
_version_ | 1784654968141119488 |
---|---|
author | Might, Matthew Crouse, Andrew B. |
author_facet | Might, Matthew Crouse, Andrew B. |
author_sort | Might, Matthew |
collection | PubMed |
description | With one in ten suffering from one of 10,000 rare diseases, precision medicine opens a path toward identifying therapies for rare patients. Conversely, it is rare patients—through their collective experience and the knowledge captured in their genetics—who open the path toward identifying therapies for common patients. |
format | Online Article Text |
id | pubmed-8861960 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-88619602022-03-02 Why rare disease needs precision medicine—and precision medicine needs rare disease Might, Matthew Crouse, Andrew B. Cell Rep Med Commentary With one in ten suffering from one of 10,000 rare diseases, precision medicine opens a path toward identifying therapies for rare patients. Conversely, it is rare patients—through their collective experience and the knowledge captured in their genetics—who open the path toward identifying therapies for common patients. Elsevier 2022-02-15 /pmc/articles/PMC8861960/ /pubmed/35243424 http://dx.doi.org/10.1016/j.xcrm.2022.100530 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Commentary Might, Matthew Crouse, Andrew B. Why rare disease needs precision medicine—and precision medicine needs rare disease |
title | Why rare disease needs precision medicine—and precision medicine needs rare disease |
title_full | Why rare disease needs precision medicine—and precision medicine needs rare disease |
title_fullStr | Why rare disease needs precision medicine—and precision medicine needs rare disease |
title_full_unstemmed | Why rare disease needs precision medicine—and precision medicine needs rare disease |
title_short | Why rare disease needs precision medicine—and precision medicine needs rare disease |
title_sort | why rare disease needs precision medicine—and precision medicine needs rare disease |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861960/ https://www.ncbi.nlm.nih.gov/pubmed/35243424 http://dx.doi.org/10.1016/j.xcrm.2022.100530 |
work_keys_str_mv | AT mightmatthew whyrarediseaseneedsprecisionmedicineandprecisionmedicineneedsraredisease AT crouseandrewb whyrarediseaseneedsprecisionmedicineandprecisionmedicineneedsraredisease |